Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Literature
1.
Vanast WJ (1986) New daily persistent headaches: definition of a benign syndrome. Headache 26:317
2.
Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 2004; 24 (supp1):1–160
3.
Silberstein SD, Lipton RB (2001) Chronic daily headache, including transformed migraine, chronic tension-type headache and medication overuse. In: Silberstein SD, Lipton RB, Dalessio DJ (ed) Wolffs Headache and other head pain. Oxford University Press, Oxford, pp 247–282
4.
Bigal ME, Sheftell FD, Rapoport AM et al (2002) Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 22:432–438, 12133042, 10.1046/j.1468-2982.2002.00384.x, 1:STN:280:DC%2BD38visFajsg%3D%3DCrossRefPubMed
5.
Koenig MA, Gladstein J, McCarter RJ, The Pediatric Committee of the American Headache Society, et al (2002) Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache 42:491–500, 12167137, 10.1046/j.1526-4610.2002.02124.xCrossRefPubMed
6.
Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 38:497–506
7.
Rozen TD (2002) Successful treatment of new daily persistent headache with gabapentin and topiramate. Headache 42:433
8.
Evers S, Rahmann A, Vollmer-Haase J, Husstedt I-W (2002) Treatment of headache with botulinum toxin A—a review according to evidence-based medicine criteria. Cephalalgia 22:699–710, 12421155, 10.1046/j.1468-2982.2002.00390.x, 1:STN:280:DC%2BD38nmtFKnsA%3D%3DCrossRefPubMed
9.
Farinelli I, Coloprisco G, De Filippis S, Martelletti P (2006) Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain 7:407–412, 17149565, 10.1007/s10194-006-0344-9, 1:CAS:528:DC%2BD2sXkt1Sjsw%3D%3DPubMedCentralCrossRefPubMed
Metadata
Title
Efficacy of botulinum toxin type A in new daily persistent headache
Author
Roderick C. Spears
Publication date
01-12-2008
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 6/2008
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-008-0078-y

Other articles of this Issue 6/2008

The Journal of Headache and Pain 6/2008 Go to the issue

Brief Report

Sporadic hemiplegic migraine: report of a case with clinical and radiological features

Original

Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium

Brief Report

Relapsing remitting hypnic headache responsive to indomethacin in an adolescent: a case report

Original

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan

Brief Report

An often unrecognized cause of thunderclap headache: reversible cerebral vasoconstriction syndrome

Original Article

A cross-sectional population-based survey of migraine and headache in 21,177 Norwegians: the Akershus sleep apnea project